top | item 19440095

(no title)

Frqy3 | 7 years ago

Not testing on women, and particularly avoiding pregnant women, is how to end up with another thalidomide case.

Sure, you wouldn't want pregnant women to be amongst your first field test subjects. But you do want them to be included as part of the carefully monitored testing period, rather than wait until the drug goes commercial and there is not the same focus on looking for and collecting data on side effects.

discuss

order

No comments yet.